Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults (age 18 and older)
Located in the CVICU
FDA approved permanent pacemaker in place (inclusive of dual-chamber and Bi-Ventricular ICDs) with labeling that allows backup pacing setting at 100 bpm.
Receiving a vasopressor or Inotrope for at least 4 hours
Average HR ≤ 75 bpm over the last hour (on Telemetry review)
Pulmonary artery catheter in place with functioning thermistor and pulmonary artery port.
You may not be if
Single chamber Implantable Cardiac Defibrillator
Sinus rhythm with a leadless pacemaker
Ventricular Tachycardia or Ventricular Fibrillation arrest in last 48 hours
Hemodynamic instability within the last 4 hours, defined as an increase in the dose of norepinephrine \> 10 mcg/min, an increase of epinephrine \> 10 mcg/kg/min, or initiation of a second vasopressor
Alternative indication for pacing rate change (i.e Torsade de Pointes, Recurrent Ventricular Tachycardia)
Comfort-focused care or anticipated death within 24 hours
Mechanical circulatory support in place
Newly discovered pacing system malfunction (lead displacement, loss of capture, elevated capture threshold, significant lead impedance change, battery depletion, undersensing or oversensing)
